Treatment of macular seborrheic keratoses using a novel 1927-nm fractional thulium fiber laser.
Identifieur interne : 000331 ( PubMed/Checkpoint ); précédent : 000330; suivant : 000332Treatment of macular seborrheic keratoses using a novel 1927-nm fractional thulium fiber laser.
Auteurs : Kristel D. Polder [États-Unis] ; Anum Mithani ; April Harrison ; Suzanne BruceSource :
- Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] [ 1524-4725 ] ; 2012.
Descripteurs français
- KwdFr :
- MESH :
- anatomopathologie : Kératose séborrhéique.
- effets indésirables : Lasers à solide.
- usage thérapeutique : Lasers à solide.
- étiologie : Douleur, Oedème, Érythème.
- Adulte d'âge moyen, Humains, Kératose séborrhéique, Mâle, Résultat thérapeutique, Sujet âgé, Thulium.
English descriptors
- KwdEn :
- MESH :
- chemical : Thulium.
- adverse effects : Lasers, Solid-State.
- etiology : Edema, Erythema, Pain.
- pathology : Keratosis, Seborrheic.
- surgery : Keratosis, Seborrheic.
- therapeutic use : Lasers, Solid-State.
- Aged, Humans, Male, Middle Aged, Treatment Outcome.
Abstract
Macular seborrheic keratoses (SK) are common, benign growths. A novel fractionated 1927-nm thulium fiber laser was selected to investigate efficacy and safety in the clearance of macular SK in nonfacial areas at a private dermatologic laser center.
DOI: 10.1111/j.1524-4725.2012.02427.x
PubMed: 22563723
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:22563723Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of macular seborrheic keratoses using a novel 1927-nm fractional thulium fiber laser.</title>
<author><name sortKey="Polder, Kristel D" sort="Polder, Kristel D" uniqKey="Polder K" first="Kristel D" last="Polder">Kristel D. Polder</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Dermatology, University of Texas Southwestern Medical School, Dallas, Texas, USA. kristelpolder@hotmail.com</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Dermatology, University of Texas Southwestern Medical School, Dallas, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mithani, Anum" sort="Mithani, Anum" uniqKey="Mithani A" first="Anum" last="Mithani">Anum Mithani</name>
</author>
<author><name sortKey="Harrison, April" sort="Harrison, April" uniqKey="Harrison A" first="April" last="Harrison">April Harrison</name>
</author>
<author><name sortKey="Bruce, Suzanne" sort="Bruce, Suzanne" uniqKey="Bruce S" first="Suzanne" last="Bruce">Suzanne Bruce</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="doi">10.1111/j.1524-4725.2012.02427.x</idno>
<idno type="RBID">pubmed:22563723</idno>
<idno type="pmid">22563723</idno>
<idno type="wicri:Area/PubMed/Corpus">000366</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000366</idno>
<idno type="wicri:Area/PubMed/Curation">000366</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000366</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000366</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000366</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Treatment of macular seborrheic keratoses using a novel 1927-nm fractional thulium fiber laser.</title>
<author><name sortKey="Polder, Kristel D" sort="Polder, Kristel D" uniqKey="Polder K" first="Kristel D" last="Polder">Kristel D. Polder</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Dermatology, University of Texas Southwestern Medical School, Dallas, Texas, USA. kristelpolder@hotmail.com</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Dermatology, University of Texas Southwestern Medical School, Dallas, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mithani, Anum" sort="Mithani, Anum" uniqKey="Mithani A" first="Anum" last="Mithani">Anum Mithani</name>
</author>
<author><name sortKey="Harrison, April" sort="Harrison, April" uniqKey="Harrison A" first="April" last="Harrison">April Harrison</name>
</author>
<author><name sortKey="Bruce, Suzanne" sort="Bruce, Suzanne" uniqKey="Bruce S" first="Suzanne" last="Bruce">Suzanne Bruce</name>
</author>
</analytic>
<series><title level="j">Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]</title>
<idno type="eISSN">1524-4725</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Edema (etiology)</term>
<term>Erythema (etiology)</term>
<term>Humans</term>
<term>Keratosis, Seborrheic (pathology)</term>
<term>Keratosis, Seborrheic (surgery)</term>
<term>Lasers, Solid-State (adverse effects)</term>
<term>Lasers, Solid-State (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pain (etiology)</term>
<term>Thulium</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Douleur (étiologie)</term>
<term>Humains</term>
<term>Kératose séborrhéique ()</term>
<term>Kératose séborrhéique (anatomopathologie)</term>
<term>Lasers à solide (effets indésirables)</term>
<term>Lasers à solide (usage thérapeutique)</term>
<term>Mâle</term>
<term>Oedème (étiologie)</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Thulium</term>
<term>Érythème (étiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Thulium</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lasers, Solid-State</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Kératose séborrhéique</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lasers à solide</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Edema</term>
<term>Erythema</term>
<term>Pain</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Keratosis, Seborrheic</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Keratosis, Seborrheic</term>
</keywords>
<keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Lasers, Solid-State</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Lasers à solide</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Douleur</term>
<term>Oedème</term>
<term>Érythème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Humains</term>
<term>Kératose séborrhéique</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Thulium</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Macular seborrheic keratoses (SK) are common, benign growths. A novel fractionated 1927-nm thulium fiber laser was selected to investigate efficacy and safety in the clearance of macular SK in nonfacial areas at a private dermatologic laser center.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">22563723</PMID>
<DateCreated><Year>2012</Year>
<Month>07</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted><Year>2012</Year>
<Month>10</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4725</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>38</Volume>
<Issue>7 Pt 1</Issue>
<PubDate><Year>2012</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]</Title>
<ISOAbbreviation>Dermatol Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Treatment of macular seborrheic keratoses using a novel 1927-nm fractional thulium fiber laser.</ArticleTitle>
<Pagination><MedlinePgn>1025-31</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1524-4725.2012.02427.x</ELocationID>
<Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Macular seborrheic keratoses (SK) are common, benign growths. A novel fractionated 1927-nm thulium fiber laser was selected to investigate efficacy and safety in the clearance of macular SK in nonfacial areas at a private dermatologic laser center.</AbstractText>
<AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Six subjects (average age 56.8 ± 9.5) with at least four 3-mm or larger macular SK on one extremity, neck, or chest were enrolled and provided informed consent. Subjects received three treatments at 3- to 4-week intervals. Subjects were treated at settings of 10 to 20 mJ with 30% to 55% surface area coverage and four to eight passes at each session. Investigators performed a global extremity SK count, an SK count within a 5- by 5-cm (25 cm(2)) square on transparency mapping, and lesion thickness grading. Side effects were assessed. Patients rated pain using a visual analog scale.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">At baseline, average global SK count was 43.2 ± 27.3. At 1-month follow-up, 20.7 ± 16.6 lesions remained. At 3- and 6-month follow-up, 17.7 ± 23.8 and 14.7 ± 18.6 lesions remained, respectively. A decrease in thickness and SK counts within the 5- by 5-cm square was also observed. Moderate erythema and mild edema were post-treatment responses.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Nonablative fractional resurfacing using the 1927-nm thulium fiber laser is a safe and effective treatment modality to decrease nonfacial macular SK.</AbstractText>
<CopyrightInformation>© 2012 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Polder</LastName>
<ForeName>Kristel D</ForeName>
<Initials>KD</Initials>
<AffiliationInfo><Affiliation>Department of Dermatology, University of Texas Southwestern Medical School, Dallas, Texas, USA. kristelpolder@hotmail.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mithani</LastName>
<ForeName>Anum</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Harrison</LastName>
<ForeName>April</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bruce</LastName>
<ForeName>Suzanne</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2012</Year>
<Month>05</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Dermatol Surg</MedlineTA>
<NlmUniqueID>9504371</NlmUniqueID>
<ISSNLinking>1076-0512</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>8RKC5ATI4P</RegistryNumber>
<NameOfSubstance UI="D013932">Thulium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Dermatol Surg. 2012 Jul;38(7 Pt 1):1032</RefSource>
<PMID Version="1">22759223</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004487">Edema</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004890">Erythema</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D017492">Keratosis, Seborrheic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D053844">Lasers, Solid-State</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010146">Pain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013932">Thulium</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="aheadofprint"><Year>2012</Year>
<Month>5</Month>
<Day>4</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>5</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>5</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>10</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-4725.2012.02427.x</ArticleId>
<ArticleId IdType="pubmed">22563723</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Texas</li>
</region>
</list>
<tree><noCountry><name sortKey="Bruce, Suzanne" sort="Bruce, Suzanne" uniqKey="Bruce S" first="Suzanne" last="Bruce">Suzanne Bruce</name>
<name sortKey="Harrison, April" sort="Harrison, April" uniqKey="Harrison A" first="April" last="Harrison">April Harrison</name>
<name sortKey="Mithani, Anum" sort="Mithani, Anum" uniqKey="Mithani A" first="Anum" last="Mithani">Anum Mithani</name>
</noCountry>
<country name="États-Unis"><region name="Texas"><name sortKey="Polder, Kristel D" sort="Polder, Kristel D" uniqKey="Polder K" first="Kristel D" last="Polder">Kristel D. Polder</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000331 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000331 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Terre |area= ThuliumV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:22563723 |texte= Treatment of macular seborrheic keratoses using a novel 1927-nm fractional thulium fiber laser. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:22563723" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a ThuliumV1
![]() | This area was generated with Dilib version V0.6.21. | ![]() |